Chief Financial Officer
With over a decade of finance leadership experience in the healthcare sector, Mr. Carter is a seasoned executive dedicated to driving financial excellence and strategic growth. He joined The Oncology Institute in 2021 as Vice President of Finance and was promoted to Senior Vice President in 2023. In this role, he oversaw corporate finance, financial planning and analysis (FP&A), treasury and investor relations, playing a crucial role in shaping the organization’s financial strategy.
Rob is known for his ability to build high-performing teams and enhance financial and non-financial reporting processes, leveraging analytics to inform actionable business strategies. His extensive background spans various healthcare sectors, including pharmaceutical finance, Medicare Advantage, Medi-Cal, and physician group practices.
Before joining The Oncology Institute, Rob served as Head of FP&A at Hoag Health System, a multi-specialty physician group practice and management services organization (MSO). He also held several leadership positions in FP&A at SCAN Health Plan and McKesson US Pharma, where he honed his skills in financial management and strategic planning.